Roche gets EMA panel nod for conditional approval of Lunsumio for blood cancer subtype in EU

Retrieved on: 2022-04-22 14:24:52

Tags for this article:

Medical specialties

Clinical medicine

European Medicines Agency

Follicular lymphoma

Committee for Medicinal Products for Human Use

Duvelisib

Getty Images

Roche

Click the tags to see associated articles and topics

Roche gets EMA panel nod for conditional approval of Lunsumio for blood cancer subtype in EU. View article details on HISWAI: https://seekingalpha.com/news/3825799-roche-gets-ema-panel-nod-for-eu-conditional-approval-of-lunsumio-for-blood-cancer-subtype

Excerpt

A committee of the European Medicines Agency (EMA) recommended the conditional approval of Roche' (RHHBY) (RHHBF) Lunsumio to treat adult patients ...

Article found on: seekingalpha.com

View Original Article